BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 85732)

  • 1. [Chemotherapy of hepatocytoma--discrepancies between AFP activity and the progress of the disease].
    Imaeda T; Suzuki M; Matayoshi J; Doi H
    Rinsho Hoshasen; 1979; 24(2):335-6. PubMed ID: 85732
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early diagnosis of the hepatocellular carcinoma (author's transl)].
    Imaeda T; Suzuki M; Yanagawa S; Doi H
    Rinsho Hoshasen; 1979 Mar; 24(3):423-4. PubMed ID: 94932
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment.
    Rahmi G; Malka D; Tomasic G; Dromain C; Ducreux M; Boige V
    J Clin Oncol; 2007 Jun; 25(16):e15-6. PubMed ID: 17538153
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent.
    Chen LT; Shiah HS; Chao Y; Chang JY; Cheng LT; Whang-Peng J
    J Clin Oncol; 2009 Dec; 27(36):e271; author reply e272. PubMed ID: 19917866
    [No Abstract]   [Full Text] [Related]  

  • 5. [Early diagnosis of hepatocellular carcinoma (author's transl)].
    Yanagawa S; Suzuki M; Imaeda T; Doi H
    Rinsho Hoshasen; 1979 Jun; 24(6):701-2. PubMed ID: 88532
    [No Abstract]   [Full Text] [Related]  

  • 6. Testing for AFP in combination with ultrasound improves early liver cancer detection.
    Tzartzeva K; Singal AG
    Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):947-949. PubMed ID: 30118333
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic hepatitis C presenting with a diagnosis of hepatocellular carcinoma].
    Hallager S; Weis N
    Ugeskr Laeger; 2014 Aug; 176(33):. PubMed ID: 25293410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of sonography in diagnosing hepatocellular carcinoma.
    Tarantino G
    AJR Am J Roentgenol; 2007 May; 188(5):W494; author reply W495. PubMed ID: 17449752
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma.
    Kilickap S; Arslan C; Senel S; Ataseven H
    J Clin Oncol; 2010 Feb; 28(6):e99; author reply e100. PubMed ID: 20085931
    [No Abstract]   [Full Text] [Related]  

  • 10. An Unusual Cause of a Liver Mass in a Woman.
    Evers L; Patel D; Porayko M
    Gastroenterology; 2018 Aug; 155(2):e17-e18. PubMed ID: 29410355
    [No Abstract]   [Full Text] [Related]  

  • 11. Spontaneous regression of hepatocellular carcinoma.
    Gottfried EB; Steller R; Paronetto F; Lieber CS
    Gastroenterology; 1982 Apr; 82(4):770-4. PubMed ID: 6174388
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of scintigraphy, CT and serum alpha-fetoprotein in patients with hepatocellular carcinoma].
    Ono S; Hoshi H; Jinnouchi M; Tsukino H; Wakuta Y; Watanake K
    Rinsho Hoshasen; 1986 Dec; 31(13):1521-5. PubMed ID: 2434693
    [No Abstract]   [Full Text] [Related]  

  • 13. Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy.
    Buamah PK; Cornell C; James OF; Skillen AW; Harris AL
    Cancer Chemother Pharmacol; 1986; 17(2):182-4. PubMed ID: 2424626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma. Frequency of diffuse inhomogenous forms in ultrasonography and comparative value of alphafetoprotein and ultrasonically guided fine needle aspiration biopsy.
    Sautereau D; Berry P; Cessot F; Gainant A; Pillegand B
    J Hepatol; 1992 Mar; 14(2-3):413-5. PubMed ID: 1380029
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatocellular carcinoma, appearance on computed tomography].
    Rangheard AS; Menu Y; Bléry M
    Presse Med; 2006 Apr; 35(4 Pt 2):728-9. PubMed ID: 16614622
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of advanced hepatocellular carcinoma responding to suppository of Tegafur].
    Kudo K; Arakawa A; Takagi Y; Nishimura R; Yamashita Y; Takahashi M
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):747-50. PubMed ID: 9571975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embryo extracts opotherapy reduces alpha-fetoprotein levels in hepatocellular carcinoma patients.
    Franchi F; Ielapi T; Bizzarri M; Seminara P
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1467-8. PubMed ID: 16105144
    [No Abstract]   [Full Text] [Related]  

  • 18. [Angiographic diagnosis of resectable hepatocellular carcinoma (author's transl)].
    Ariyama J; Ikenobe H; Shirata I; Sumida M; Shimaguchi S; Misumi K; Gondo M; Shirakabe H; Sugahara K; Kawano N
    Rinsho Hoshasen; 1979 Jan; 24(1):73-80. PubMed ID: 84083
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radioimmunoimaging of hepatic tumors with 131I labeled polyclonal antibody against alpha-fetoprotein (AFP)].
    Koizumi K; Aburano T; Yokoyama K; Watanabe N; Kawabata S; Shuke N; Mukai K; Tonami N; Hisada K; Tanaka N
    Kaku Igaku; 1986 Apr; 23(4):397-401. PubMed ID: 2426486
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma.
    Vora SR; Zheng H; Stadler ZK; Fuchs CS; Zhu AX
    Oncologist; 2009 Jul; 14(7):717-25. PubMed ID: 19581525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.